share_log
Breakings ·  Oct 31 22:44
Neurocrine Biosciences Inc : BMO Raises Target Price to $121 From $114
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment